Amylx Pharmaceuticals Inc vs FTAI Aviation Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while FTAI Aviation Ltd trades at $226.98 (market cap $23.17B). The key difference: FTAI Aviation Ltd is far larger — about 8.8× Amylx Pharmaceuticals Inc's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | FTAI | |
|---|---|---|
Market Cap | $2.64B | $23.17B |
Sector | Health | Industrials |
52-Week High | $24.19 | $310.04 |
52-Week Low | $7.82 | $140.40 |
Enterprise Value | $2.39B | $26.29B |
Dividend Yield | — | 0.89% |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →